
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29215079</article-id><article-id pub-id-type="pmc">5719359</article-id><article-id pub-id-type="publisher-id">17449</article-id><article-id pub-id-type="doi">10.1038/s41598-017-17449-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Design and synthesis of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole derivatives as colchicine binding site inhibitors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Yue</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Dongjie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Meiqi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhiwei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Zhenzhen</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Guan</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zuo</surname><given-names>Daiying</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sun</surname><given-names>Jun</given-names></name><address><email>Jun_84@163.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Yingliang</given-names></name><address><email>yingliang_1016@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Weige</given-names></name><address><email>zhangweige@syphu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8645 4345</institution-id><institution-id institution-id-type="GRID">grid.412561.5</institution-id><institution>Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, </institution><institution>Shenyang Pharmaceutical University, </institution></institution-wrap>103 Wenhua Road, Shenhe District Shenyang, 110016 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8645 4345</institution-id><institution-id institution-id-type="GRID">grid.412561.5</institution-id><institution>Department of Pharmacology, </institution><institution>Shenyang Pharmaceutical University, </institution></institution-wrap>103 Wenhua Road, Shenhe District Shenyang, 110016 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8645 4345</institution-id><institution-id institution-id-type="GRID">grid.412561.5</institution-id><institution>Wuya College of Innovation, </institution><institution>Shenyang Pharmaceutical University, </institution></institution-wrap>103 Wenhua Road, Shenhe District Shenyang, 110016 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2189 3846</institution-id><institution-id institution-id-type="GRID">grid.207374.5</institution-id><institution>Clinical Pharmacology Laboratory, Henan Province People&#x02019;s Hospital, </institution><institution>Zhengzhou University People&#x02019;s Hospital, </institution></institution-wrap>7 Weiwu Road, Jinshui District Zhengzhou, 450003 China </aff></contrib-group><pub-date pub-type="epub"><day>7</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>7</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>17120</elocation-id><history><date date-type="received"><day>13</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">A series of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazol derivatives were designed as potential microtubule targeting agents. The regioselective alkylation of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole was predicted by computations and confirmed by an unambiguous synthetic route. The antiproliferative activity of the synthesized compounds was tested <italic>in vitro</italic> using three human cancer cell lines and some compounds exhibited significant antiproliferative activity, which suggested the reasonability of introduction of the 1,2,3-triazole fragment. Among them, compound <bold>7p</bold> showed highest activity with the IC<sub>50</sub> values at nanomolar level towards all three cell lines, which were comparable to the positive control, CA-4. Tubulin polymerization assay, immunofluorescence studies, cell cycle analysis and competitive tubulin-binding assay strongly proved that <bold>7p</bold> is a colchicine binding site inhibitor of tubulin. Thus, <bold>7p</bold> was identified as a promising drug candidate for further development of colchicine binding site inhibitors.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Microtubules play crucial roles in cellular structure and various aspects of cell functions. The polymerization dynamics of microtubules are vital during mitosis, which is regarded as a promising target for cancer therapy since it can be profoundly affected by even small molecules<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Microtubule targeted agents can be classified into two major classes: microtubule-stabilizing agents which stimulate microtubule polymerization, such as paclitaxel (taxol); microtubule-destabilizing agents which inhibit polymerization of tubulin, include vinblastine and colchicine (<bold>1</bold>, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Structure of CBSIs.</p></caption><graphic xlink:href="41598_2017_17449_Fig1_HTML" id="d29e364"/></fig>
</p><p id="Par3">Although colchicine can significantly inhibit the polymerization of tubulin, its therapeutic application is limited by the low therapeutic index. To overcome the disadvantages of colchicine, it is desired to find novel compounds that target at the colchicine binding site and exert their biological effects by inhibiting tubulin assembly and suppressing microtubule formation. Those compounds are classified as colchicine binding site inhibitors (CBSIs)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Over decades, a large number of CBSIs have been reported, such as combretastatin A-4 (CA-4, <bold>2</bold>)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, ABT-751 (<bold>3</bold>)<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and TN16 (<bold>4</bold>)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. XRP44X (<bold>5</bold>)<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and other piperazine based CBSIs reported by Wasylyk and Chopra <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, showed potential effects on the inhibition of microtubules polymerization and the morphology of the actin cytoskeleton.</p><p id="Par4">1,2,3-Triazoles attracted our attention since tremendous compounds containing this fragment have been reported to show potent antitumor activity<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. For example, 4,5-disubstituted 1,2,3-triazole (<bold>6</bold>) was designed as an analogue of CA-4<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, which showed low IC<sub>50</sub> value at nanomolar level. Therefore, we designed a series of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole derivatives (<bold>7</bold>) and 2-alkyl-5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole derivatives (<bold>8</bold>) by replacing the pyrazole of XRP44X with 1,2,3-triazole. Meanwhile, those compounds showed well performance on molecular modeling studies. To access 2-alkylated derivatives, the regioselective alkylation of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole was investigated by computational before actual synthesis. Antiproliferative activity of all compounds was evaluated, and several compounds with considerable activity had been found. The compound with the highest antiproliferative activity was thought as a colchicine binding site inhibitor by further investigation.</p></sec><sec id="Sec2" sec-type="results"><title>Result and Discussion</title><sec id="Sec3"><title>Molecular design</title><p id="Par5">By replacing the pyrazole of XRP44X with 1,2,3-triazole, <bold>7b</bold> was designed. XRP44X possess a methyl group on the five-member ring, and previously study suggested that the methyl group was critical for bioactivity<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Thus, <bold>8b</bold> that possess a methyl group on N-2 of 1,2,3-triazole was designed.</p><p id="Par6">We further carried out the molecular docking for <bold>7b</bold> and <bold>8b</bold> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Both of them were superimposed well with <bold>5</bold>. The carbonyl group contributes a hydrogen bond to &#x003b2;-Ala317 for these three ligands. Although <bold>7b</bold> lacked a methyl group, its 2<italic>-</italic>H on 1,2,3-triazoe ring could contribute a hydrogen bond to &#x003b2;-Thr353. It suggested the desired compounds are promising for inhibition of tubulin polymerization and a series of derivates (<bold>7</bold>, <bold>8</bold>) were further designed and synthesized for biological investigation.<fig id="Fig2"><label>Figure 2</label><caption><p>Design strategy of and docked pose of desired compounds. <bold>5</bold> (green), <bold>7b</bold> (blue) and <bold>8b</bold> (red) in the colchicine binding pocket (PDB code: 3HKC).</p></caption><graphic xlink:href="41598_2017_17449_Fig2_HTML" id="d29e505"/></fig>
</p></sec><sec id="Sec4"><title>Chemistry</title><p id="Par7">All desired compounds (<bold>7</bold>, <bold>8</bold>) were obtained by following the synthetic route outlined in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. Commercially available arylacetylene derivatives (<bold>9</bold>) were used as the starting materials, which were transferred into arylpropiolaldehyde derivatives (10) by the formulation of acetylides with DMF<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Then, azide&#x02013;alkyne 1,3-dipolar cycloadditions was carried out for obtaining 5-aryl-2<italic>H</italic>-1,2,3-triazole-4-carbaldehyde (<bold>11)</bold>, followed by oxidation into 5-aryl-2<italic>H</italic>-1,2,3-triazole-4-carboxylic acid (12) with hydrogen peroxide<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Finally, amidations were carried by EDCI and HOBt to generate the desired compounds <bold>7a</bold>-<bold>7t</bold>.<fig id="Fig3"><label>Figure 3</label><caption><p>Synthetic route of all compounds. Reagents and conditions: (<bold>a</bold>) 1) <italic>n</italic>-BuLi (2.5&#x02009;M in hexane), THF, &#x02212;40&#x02009;&#x000b0;C, 30&#x02009;min; 2) DMF, &#x02212;40&#x02009;&#x000b0;C, 3) r.t., 1&#x02009;h; (<bold>b</bold>) NaN<sub>3</sub>, DMSO, r.t., 30&#x02009;min; (<bold>c</bold>) H<sub>2</sub>O<sub>2</sub>, KOH, MeOH, 30&#x02009;min; (<bold>d</bold>) arylpiperazine, EDCI, HOBt, ethyl acetate, r.t., overnight; (<bold>e</bold>) (R<sub>3</sub>)<sub>2</sub>SO<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, acetone, r.t., 1~3&#x02009;h. or R<sub>3</sub>Br, K<sub>2</sub>CO<sub>3</sub>, KI, acetone, r.t., 2~4&#x02009;h.</p></caption><graphic xlink:href="41598_2017_17449_Fig3_HTML" id="d29e610"/></fig>
</p><p id="Par8">Direct alkylation of <bold>7</bold> may produce three different products since the tautomerism of 1,2,3-triazole. Previously studies suggested that similar substrates<sup><xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref></sup> prone to generate N-2 alkylated products. In our case, density functional theory (DFT) computations were carried out for three tautomers of <bold>7</bold> to further predict the alkylated products. It showed that 2<italic>H</italic>-tautomers always have lowest energy in acetone. The results of computations were obtained for the all <bold>7</bold> substrates, as shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. The energy of 2<italic>H</italic>-tautomers, lower than 1<italic>H</italic>- and 3<italic>H</italic>-tautomers, suggested N-2 alkylation products would be the principal products.<fig id="Fig4"><label>Figure 4</label><caption><p>DFT computations of three tautomers of 7.</p></caption><graphic xlink:href="41598_2017_17449_Fig4_HTML" id="d29e654"/></fig>
</p><p id="Par9">To further verify the structures of the alkylated products, we synthesized several representative compounds by an unambiguous synthetic route (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). 4,5-Dibrome-2-methyl-2<italic>H</italic>-1,2,3-triazole (<bold>13</bold>) was synthesized by the reported methods<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Then, Grignard reaction was carried out to yield <bold>14</bold>
<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. 5-Aryl was installed by Suzuki coupling to obtain <bold>15</bold>
<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, followed by oxidation and amidation to generate <bold>8g</bold>, <bold>8h</bold>, and <bold>8i</bold>. These three compounds were proven as identical as the principal products obtained from the synthetic route in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig5"><label>Figure 5</label><caption><p>An unambiguous synthetic route for <bold>8g</bold>, <bold>8h</bold> and <bold>8i</bold>. Reagents and conditions: (<bold>a</bold>) 1) <italic>i</italic>-PrMgCl, THF, &#x02212;45&#x02009;&#x000b0;C, 30&#x02009;min; 2) DMF, &#x02212;45&#x02009;&#x000b0;C, 15&#x02009;min; (<bold>b</bold>) arylboric acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, water/dioxane, 100&#x02009;&#x000b0;C, 3&#x02009;h; (<bold>c</bold>) H<sub>2</sub>O<sub>2</sub>, KOH, MeOH, 30&#x02009;min; (<bold>d</bold>) arylpiperazine, EDCI, HOBt, ethyl acetate, r.t., overnight.</p></caption><graphic xlink:href="41598_2017_17449_Fig5_HTML" id="d29e751"/></fig>
</p></sec><sec id="Sec5"><title><italic>In vitro</italic> antiproliferative activity and structure-activity relationship</title><p id="Par10">The synthesized compounds (<bold>7</bold>, <bold>8</bold>) were investigated for their antiproliferative activity against cancer cells by MTT assay. Three human carcinoma cell lines including gastric adenocarcinoma SGC-7901 cells, lung adenocarcinoma A549 cells and fibrosarcoma HT-1080 cells were used. Two of the most well-known CBSIs, colchicine (<bold>1</bold>) and CA-4 (<bold>2</bold>) were evaluated as positive controls (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Antiproliferative activity of target compounds (7~8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">compound</th><th colspan="3">Structure</th><th colspan="3">IC<sub>50</sub> (&#x003bc;M)</th></tr><tr><th>R<sub>1</sub>
</th><th>R<sub>2</sub>
</th><th>R<sub>3</sub>
</th><th>SGC-7901</th><th>A549</th><th>HT-1080</th></tr></thead><tbody><tr><td>
<bold>7a</bold>
</td><td>H</td><td>H</td><td>H</td><td>14.4&#x02009;&#x000b1;&#x02009;0.6</td><td>49.0&#x02009;&#x000b1;&#x02009;0.6</td><td>43.0&#x02009;&#x000b1;&#x02009;0.9</td></tr><tr><td>
<bold>7b</bold>
</td><td>H</td><td>3-chloro</td><td>H</td><td>1.22&#x02009;&#x000b1;&#x02009;0.03</td><td>1.30&#x02009;&#x000b1;&#x02009;0.06</td><td>2.38&#x02009;&#x000b1;&#x02009;0.04</td></tr><tr><td>
<bold>7c</bold>
</td><td>H</td><td>4-methyl</td><td>H</td><td>2.08&#x02009;&#x000b1;&#x02009;0.04</td><td>13.2&#x02009;&#x000b1;&#x02009;0.5</td><td>4.64&#x02009;&#x000b1;&#x02009;0.19</td></tr><tr><td>
<bold>7d</bold>
</td><td>H</td><td>3-methoxy</td><td>H</td><td>0.704&#x02009;&#x000b1;&#x02009;0.031</td><td>0.600&#x02009;&#x000b1;&#x02009;0.022</td><td>1.37&#x02009;&#x000b1;&#x02009;0.05</td></tr><tr><td>
<bold>7e</bold>
</td><td>H</td><td>2,4-dimethyl</td><td>H</td><td>5.12&#x02009;&#x000b1;&#x02009;0.22</td><td>34.0&#x02009;&#x000b1;&#x02009;0.9</td><td>6.64&#x02009;&#x000b1;&#x02009;0.28</td></tr><tr><td>
<bold>7f</bold>
</td><td>H</td><td>2,5-dimethyl</td><td>H</td><td>82.2&#x02009;&#x000b1;&#x02009;4.1</td><td>84.2&#x02009;&#x000b1;&#x02009;3.2</td><td>25.9&#x02009;&#x000b1;&#x02009;0.9</td></tr><tr><td>
<bold>7g</bold>
</td><td>H</td><td>3,4-dimethyl</td><td>H</td><td>8.04&#x02009;&#x000b1;&#x02009;0.27</td><td>12.5&#x02009;&#x000b1;&#x02009;0.2</td><td>4.75&#x02009;&#x000b1;&#x02009;0.14</td></tr><tr><td>
<bold>7h</bold>
</td><td>H</td><td>3,5-dimethyl</td><td>H</td><td>0.243&#x02009;&#x000b1;&#x02009;0.004</td><td>0.401&#x02009;&#x000b1;&#x02009;0.016</td><td>0.580&#x02009;&#x000b1;&#x02009;0.027</td></tr><tr><td>
<bold>7i</bold>
</td><td>
<bold>H</bold>
</td><td>
<bold>2,5-dimethoxy</bold>
</td><td>
<bold>H</bold>
</td><td>
<bold>0.368&#x02009;&#x000b1;&#x02009;0.007</bold>
</td><td>
<bold>0.366&#x02009;&#x000b1;&#x02009;0.018</bold>
</td><td>
<bold>0.254&#x02009;&#x000b1;&#x02009;0.005</bold>
</td></tr><tr><td>
<bold>7j</bold>
</td><td>H</td><td>3,5-dimethoxy</td><td>H</td><td>0.107&#x02009;&#x000b1;&#x02009;0.002</td><td>0.067&#x02009;&#x000b1;&#x02009;0.001</td><td>0.050&#x02009;&#x000b1;&#x02009;0.001</td></tr><tr><td>
<bold>7k</bold>
</td><td>2-fluoro</td><td>3,5-dimethyl</td><td>H</td><td>0.236&#x02009;&#x000b1;&#x02009;0.005</td><td>0.215&#x02009;&#x000b1;&#x02009;0.011</td><td>0.260&#x02009;&#x000b1;&#x02009;0.005</td></tr><tr><td>
<bold>7l</bold>
</td><td>2-fluoro</td><td>3,5-dimethoxy</td><td>H</td><td>0.254&#x02009;&#x000b1;&#x02009;0.003</td><td>0.236&#x02009;&#x000b1;&#x02009;0.012</td><td>0.561&#x02009;&#x000b1;&#x02009;0.017</td></tr><tr><td>
<bold>7m</bold>
</td><td>3-fluoro</td><td>3,5-dimethoxy</td><td>H</td><td>0.165&#x02009;&#x000b1;&#x02009;0.008</td><td>0.191&#x02009;&#x000b1;&#x02009;0.003</td><td>0.190&#x02009;&#x000b1;&#x02009;0.008</td></tr><tr><td>
<bold>7n</bold>
</td><td>4-fluoro</td><td>3,5-dimethyl</td><td>H</td><td>0.477&#x02009;&#x000b1;&#x02009;0.009</td><td>0.532&#x02009;&#x000b1;&#x02009;0.019</td><td>0.980&#x02009;&#x000b1;&#x02009;0.024</td></tr><tr><td>
<bold>7o</bold>
</td><td>4-fluoro</td><td>3,5-dimethoxy</td><td>H</td><td>0.493&#x02009;&#x000b1;&#x02009;0.017</td><td>0.447&#x02009;&#x000b1;&#x02009;0.02</td><td>1.05&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td>
<bold>7p</bold>
</td><td>
<bold>2-chloro</bold>
</td><td>
<bold>3,5-dimethoxy</bold>
</td><td>
<bold>H</bold>
</td><td>
<bold>0.052&#x02009;&#x000b1;&#x02009;0.002</bold>
</td><td>
<bold>0.029&#x02009;&#x000b1;&#x02009;0.0005</bold>
</td><td>
<bold>0.005&#x02009;&#x000b1;&#x02009;0.0002</bold>
</td></tr><tr><td>
<bold>7q</bold>
</td><td>3-chloro</td><td>3,5-dimethyl</td><td>H</td><td>0.488&#x02009;&#x000b1;&#x02009;0.016</td><td>0.508&#x02009;&#x000b1;&#x02009;0.022</td><td>0.434&#x02009;&#x000b1;&#x02009;0.012</td></tr><tr><td>
<bold>7r</bold>
</td><td>3-chloro</td><td>3,5-dimethoxy</td><td>H</td><td>0.509&#x02009;&#x000b1;&#x02009;0.014</td><td>0.449&#x02009;&#x000b1;&#x02009;0.02</td><td>0.389&#x02009;&#x000b1;&#x02009;0.006</td></tr><tr><td>
<bold>7s</bold>
</td><td>3-bromo</td><td>3,5-dimethoxy</td><td>H</td><td>10.1&#x02009;&#x000b1;&#x02009;0.3</td><td>11.2&#x02009;&#x000b1;&#x02009;0.2</td><td>9.81&#x02009;&#x000b1;&#x02009;0.47</td></tr><tr><td>
<bold>7t</bold>
</td><td>3-methyl</td><td>3,5-dimethoxy</td><td>H</td><td>0.739&#x02009;&#x000b1;&#x02009;0.017</td><td>0.310&#x02009;&#x000b1;&#x02009;0.014</td><td>0.352&#x02009;&#x000b1;&#x02009;0.011</td></tr><tr><td>
<bold>8a</bold>
</td><td>H</td><td>H</td><td>methyl</td><td>10.8&#x02009;&#x000b1;&#x02009;0.3</td><td>4.52&#x02009;&#x000b1;&#x02009;0.12</td><td>4.45&#x02009;&#x000b1;&#x02009;0.11</td></tr><tr><td>
<bold>8b</bold>
</td><td>H</td><td>3-chloro</td><td>methyl</td><td>1.05&#x02009;&#x000b1;&#x02009;0.01</td><td>1.10&#x02009;&#x000b1;&#x02009;0.05</td><td>0.841&#x02009;&#x000b1;&#x02009;0.035</td></tr><tr><td>
<bold>8c</bold>
</td><td>H</td><td>3-chloro</td><td>ethyl</td><td>3.10&#x02009;&#x000b1;&#x02009;0.15</td><td>14.4&#x02009;&#x000b1;&#x02009;0.4</td><td>10.0&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td>
<bold>8d</bold>
</td><td>H</td><td>3-chloro</td><td>allyl</td><td>6.22&#x02009;&#x000b1;&#x02009;0.17</td><td>81.0&#x02009;&#x000b1;&#x02009;2.6</td><td>37.7&#x02009;&#x000b1;&#x02009;1.2</td></tr><tr><td>
<bold>8e</bold>
</td><td>H</td><td>3-chloro</td><td>isopropyl</td><td>18.2&#x02009;&#x000b1;&#x02009;0.6</td><td>46.8&#x02009;&#x000b1;&#x02009;1.8</td><td>78.5&#x02009;&#x000b1;&#x02009;2.7</td></tr><tr><td>
<bold>8f</bold>
</td><td>H</td><td>3-chloro</td><td>butyl</td><td>6.18&#x02009;&#x000b1;&#x02009;0.14</td><td>10.0&#x02009;&#x000b1;&#x02009;0.5</td><td>&#x0003e;100</td></tr><tr><td>
<bold>8g</bold>
</td><td>H</td><td>3,5-dimethyl</td><td>methyl</td><td>0.559&#x02009;&#x000b1;&#x02009;0.014</td><td>0.882&#x02009;&#x000b1;&#x02009;0.014</td><td>0.639&#x02009;&#x000b1;&#x02009;0.019</td></tr><tr><td>
<bold>8h</bold>
</td><td>H</td><td>3,5-dimethoxy</td><td>methyl</td><td>0.442&#x02009;&#x000b1;&#x02009;0.012</td><td>0.304&#x02009;&#x000b1;&#x02009;0.009</td><td>0.515&#x02009;&#x000b1;&#x02009;0.011</td></tr><tr><td>
<bold>8i</bold>
</td><td>
<bold>2-fluoro</bold>
</td><td>
<bold>3,5-dimethyl</bold>
</td><td>
<bold>methyl</bold>
</td><td>
<bold>0.228&#x02009;&#x000b1;&#x02009;0.006</bold>
</td><td>
<bold>0.210&#x02009;&#x000b1;&#x02009;0.008</bold>
</td><td>
<bold>1.07&#x02009;&#x000b1;&#x02009;0.03</bold>
</td></tr><tr><td>
<bold>8j</bold>
</td><td>2-fluoro</td><td>3,5-dimethyl</td><td>ethyl</td><td>54.2&#x02009;&#x000b1;&#x02009;1.4</td><td>60.9&#x02009;&#x000b1;&#x02009;0.6</td><td>44.4&#x02009;&#x000b1;&#x02009;0.9</td></tr><tr><td>
<bold>8k</bold>
</td><td>2-fluoro</td><td>3,5-dimethoxy</td><td>methyl</td><td>0.162&#x02009;&#x000b1;&#x02009;0.003</td><td>0.172&#x02009;&#x000b1;&#x02009;0.008</td><td>0.165&#x02009;&#x000b1;&#x02009;0.003</td></tr><tr><td>
<bold>8l</bold>
</td><td>4-fluoro</td><td>3,5-dimethyl</td><td>methyl</td><td>0.396&#x02009;&#x000b1;&#x02009;0.018</td><td>0.686&#x02009;&#x000b1;&#x02009;0.01</td><td>0.712&#x02009;&#x000b1;&#x02009;0.009</td></tr><tr><td>
<bold>8m</bold>
</td><td>4-fluoro</td><td>3,5-dimethoxy</td><td>methyl</td><td>0.291&#x02009;&#x000b1;&#x02009;0.013</td><td>0.639&#x02009;&#x000b1;&#x02009;0.024</td><td>0.564&#x02009;&#x000b1;&#x02009;0.010</td></tr><tr><td>
<bold>8n</bold>
</td><td>3-chloro</td><td>3,5-dimethyl</td><td>methyl</td><td>0.422&#x02009;&#x000b1;&#x02009;0.009</td><td>0.461&#x02009;&#x000b1;&#x02009;0.007</td><td>0.464&#x02009;&#x000b1;&#x02009;0.016</td></tr><tr><td>
<bold>8o</bold>
</td><td>3-chloro</td><td>3,5-dimethoxy</td><td>methyl</td><td>0.448&#x02009;&#x000b1;&#x02009;0.013</td><td>0.453&#x02009;&#x000b1;&#x02009;0.011</td><td>0.475&#x02009;&#x000b1;&#x02009;0.017</td></tr><tr><td colspan="4">
<bold>Colchicine (1)</bold>
</td><td>0.134&#x02009;&#x000b1;&#x02009;0.004</td><td>0.137&#x02009;&#x000b1;&#x02009;0.006</td><td>0.042&#x02009;&#x000b1;&#x02009;0.0018</td></tr><tr><td colspan="4">
<bold>CA-4 (2)</bold>
</td><td>0.048&#x02009;&#x000b1;&#x02009;0.0009</td><td>0.034&#x02009;&#x000b1;&#x02009;0.0006</td><td>0.007&#x02009;&#x000b1;&#x02009;0.0001</td></tr></tbody></table></table-wrap>
</p><p id="Par11">At first, the effect of alkyl on N-2 of 1,2,3-triazole (R<sub>3</sub>) was evaluated. All methylated compounds showed no significant change on the activity compared with corresponding compounds without methyl (<bold>7a</bold> vs. <bold>8a</bold>, <bold>7b</bold> vs. <bold>8b</bold>, <bold>7h</bold> vs. <bold>8g</bold>, <bold>7j</bold> vs. <bold>8h</bold>, <bold>7l</bold> vs. <bold>8k</bold>, ect.). These results indicated that methyl on N-2 is unnecessary, however, activity severely declined as bulky alkyl group was introduced (<bold>8c</bold>-<bold>8f</bold> vs. <bold>8b</bold>, <bold>8j</bold> vs. <bold>8i</bold>). Then, the effect of substituents on the aryl ring linked to the piperazine fragment (R<sub>2</sub>) was investigated. Compared with <bold>7b</bold> (R<sub>2</sub>&#x02009;=&#x02009;3-chloro), both <bold>7a</bold> (R<sub>2</sub>&#x02009;=&#x02009;H) and <bold>7c</bold> (R<sub>2</sub>&#x02009;=&#x02009;4-methyl) showed dramatically decreased activity, while <bold>7d</bold> (R<sub>2</sub>&#x02009;=&#x02009;3-methoxy) also show considerable activity, which indicated steric factor is crucial on R<sub>2</sub> rather than electronegativity factor. Furthermore, di-meta-substituted compounds showed increased activity, for instance, <bold>7j</bold> (R<sub>2</sub>&#x02009;=&#x02009;3,5-dimethoxy) showed evident higher activity than <bold>7d</bold> (R<sub>2</sub>&#x02009;=&#x02009;3-methoxy). Finally, we investigated the effect of substituents on the aryl ring directly linked to 1,2,3-triazole core (R<sub>1</sub>) and found that the position and electronegativity had minimum effects on the activity. Among the designed compounds, <bold>7p</bold> (R<sub>1</sub>&#x02009;=&#x02009;2-chloro) showed an IC<sub>50</sub> value of 5~52&#x02009;nM towards all three cell lines, which was comparable to CA-4 (7~48&#x02009;nM).</p></sec><sec id="Sec6"><title>Tubulin polymerization</title><p id="Par12">
<bold>7p</bold>, the compound with the highest antiproliferative activity, was assessed its effect on the tubulin polymerization <italic>in vitro</italic>. CA-4 (2) was used as a positive control and Taxol as a negative control. As shown in Fig. 6, <bold>7p</bold> exhibited a dose-dependent inhibition of tubulin polymerization. The inhibitory activity of <bold>7p</bold> towards tubulin polymerization (IC<sub>50</sub> value, 2.06&#x02009;&#x000b5;M) was more potent than the positive control CA-4.<fig id="Fig6"><label>Figure 6</label><caption><p>Effects of <bold>7p</bold> on tubulin polymerization. Tubulin had been pre-incubated for 1&#x02009;min with <bold>7p</bold> at 1&#x02009;&#x003bc;M, 2&#x02009;&#x003bc;M, 4&#x02009;&#x003bc;M and 8&#x02009;&#x003bc;M, CA-4 at 4&#x02009;&#x003bc;M, Taxol at 5&#x02009;&#x003bc;M or vehicle DMSO.</p></caption><graphic xlink:href="41598_2017_17449_Fig6_HTML" id="d29e1943"/></fig>
</p></sec><sec id="Sec7"><title>Immunofluorescence studies</title><p id="Par13">To visualize the effects of <bold>7p</bold> toward microtubule network, immunofluorescence studies were carried out. SGC-7901 cell lines were treated for 24&#x02009;h with CA-4 and <bold>7p</bold> at their IC<sub>50</sub>. As shown in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>, both CA-4 and <bold>7p</bold> lead to radical changes in cell morphology of structured microtubules. These results indicated that <bold>7p</bold> can destabilize the microtubules of SGC-7901 cells.<fig id="Fig7"><label>Figure 7</label><caption><p>Immunofluorescence studies. CA-4 (48.1&#x02009;nM) and <bold>7p</bold> (52.0&#x02009;nM) induced depolymerization of the microtubule networks of SGC-7901 cancer cells, while untreated cells also used as control. After 24&#x02009;h, cells were fixed and stained with anti-&#x003b1;-tubulin-FITC specific antibodies followed by DAPI. Microtubules and unassembled tubulin are shown in green, and nuclei, which were stained with DAPI, are shown in blue.</p></caption><graphic xlink:href="41598_2017_17449_Fig7_HTML" id="d29e1980"/></fig>
</p></sec><sec id="Sec8"><title>Cell cycle analysis</title><p id="Par14">To evaluate the effects of <bold>7p</bold> on the cell mitosis, we have analyzed the effect of <bold>7p</bold> on the cell cycle of SGC-7901 cells by flow cytometry (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). CA-4 was also examined as a positive control. Similar as CA-4, <bold>7p</bold> arrested the cell cycle in G2/M phase significantly, increasing the percentage of cells in G2/M phase at 12&#x02009;h and 24&#x02009;h. Then, population of G2/M declined while the population of Sub-G1 raised, that indicated part of cells underwent apoptosis.<fig id="Fig8"><label>Figure 8</label><caption><p>Effects of CA-4 and <bold>7p</bold> on cell cycle. SGC-7901 cells lines treated with CA-4 (48.1&#x02009;nM) and <bold>7p</bold> (52.0&#x02009;nM) for 0, 12, 24, 36, 48, 72&#x02009;h.</p></caption><graphic xlink:href="41598_2017_17449_Fig8_HTML" id="d29e2013"/></fig>
</p></sec><sec id="Sec9"><title>Competitive tubulin-binding assay</title><p id="Par15">To confirm that <bold>7p</bold> binds to colchicine site of tubulin, we further assessed the competition between <bold>7p</bold> and colchicine for binding to tubulin via competitive binding assays (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>). CA-4 (2) and Taxol were used as the positive control and negative control, respectively<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The fluorescence of a colchicine-tubulin complex was reduced in the presence of <bold>7p</bold> in a dose-dependent manner, which indicated that <bold>7p</bold> binds at the colchicine binding site.<fig id="Fig9"><label>Figure 9</label><caption><p>Fluorescence based colchicine competitive binding assay. The competitional binding between <bold>7p</bold> and colchicine was observed.</p></caption><graphic xlink:href="41598_2017_17449_Fig9_HTML" id="d29e2051"/></fig>
</p><p id="Par16">In this study, we designed and synthesized a series of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2<italic>H</italic>-1,2,3-triazole derivatives. The N-2 regioselective alkylation of 1,2,3-triazole was predicted by computations and confirmed by an unambiguous synthetic route. Most compounds showed potent antiproliferative activity at sub-micromolar or nanomolar, which suggested the reasonability of introduction of 1,2,3-triazole fragment. <bold>7p</bold> displayed highest activity against three human carcinoma cell lines, which was comparable to the positive control, CA-4. <bold>7p</bold> also highly inhibited tubulin polymerization <italic>in vitro</italic> with IC<sub>50</sub> value was 2.06&#x02009;&#x000b5;M. The immunofluorescence studies observed that <bold>7p</bold> induced depolymerization of the microtubule networks. Cell cycle analysis displayed evident G2/M arrest and induction of apoptosis. Furthermore, <bold>7p</bold> could compete with colchicine in tubulin binding site. All those experiments suggested that <bold>7p</bold> should be a colchicine binding site inhibitor of tubulin.</p></sec></sec><sec id="Sec10" sec-type="materials|methods"><title>Methods</title><sec id="Sec11"><title>Reagents and equipment</title><p id="Par17">All reagents were commercially available and were used without further purification. The silica gel plate (HSGF-254) and silica gel (H, 200&#x02013;300 mesh) from Yantai Jiangyou silicone Development Co., Ltd. was used for preparative TLC and column chromatography, respectively. Visualization was made with UV light (254&#x02009;nm and 365&#x02009;nm). Mass spectra (MS) were obtained from Agilent Co. Ltd. on an Agilent 1100-sl mass spectrometer with an electrospray ionization source. <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectra were measured in CDCl<sub>3</sub> or d<sub>6</sub>-DMSO with TMS as the internal reference on a Bruker AVANCE spectrometer operating at 400&#x02009;MHz or 600&#x02009;MHz (<sup>1</sup>H at 400 or 600&#x02009;MHz, <sup>13</sup>C at 100&#x02009;MHz).</p></sec><sec id="Sec12"><title>Chemistry</title><p id="Par18">The detailed information is in Supplementary Information.</p></sec><sec id="Sec13"><title>Cell line and culture conditions</title><p id="Par19">The human gastric adenocarcinoma SGC-7901 cells, lung adenocarcinoma A549 cells and fibrosarcoma HT-1080 cells were purchased from Shanghai Institute of Cell Resources Center of Life Science (Shanghai, China). All cells were cultured in RPMI-1640 medium (Invitrogen, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone, USA), streptomycin and penicillin at 37&#x02009;&#x000b0;C in humidified atmosphere with 5% CO<sub>2</sub>.</p></sec><sec id="Sec14"><title>MTT assay</title><p id="Par20">MTT assays were used to measure the cell viability after treatment. Briefly, 4~10&#x02009;&#x000d7;&#x02009;10<sup>3</sup> cells/well were seeded in 96-well plates (Corning, NY, USA), cultured for 24&#x02009;h, and treated with various concentrations of compounds for 72&#x02009;h or incubated with SNP (10&#x02009;mM) or Haemoglobin (10&#x02009;mM) for 2&#x02009;h, then treated with 4d (25&#x02009;nM) for the indicated times. The DMSO concentration was kept below 0.05% in cell culture so it did not effect on cell growth. Then, MTT solution (5&#x02009;mg/mL in PBS) was added (20&#x02009;mL/well) to each well and incubated for another 4&#x02009;h at 37&#x02009;&#x000b0;C. The purple formazan crystals were dissolved in 100&#x02009;mL dimethyl sulfoxide, and the plates were read on a plate reader (MK3, Thermo, German) at 492&#x02009;nm. Experiments were repeated three times.</p></sec><sec id="Sec15"><title>Tubulin polymerization assay</title><p id="Par21">
<italic>In vitro</italic> tubulin polymerization assays were conducted as described in the manufacturer&#x02019;s protocol (Cytoskeleton, Cat.#BK011P) using 96-well plates. Briefly, <bold>7p</bold>, CA-4 or Taxol were incubated with purified porcine tubulin (2&#x02009;mg/mL) and buffer containing 10% glycerol and 1&#x02009;mM GTP at 37&#x02009;&#x000b0;C, and the effects of these compounds on tubulin polymerization were monitored kinetically for 82&#x02009;min using a plate reader (Biotek Synergy HT, Winoo-skin, VT, USA). The increase in the relative fluorescence unit (RFU) was measured at an excitation of 340&#x02009;&#x000b1;&#x02009;20&#x02009;nm and emission of 415&#x02009;&#x000b1;&#x02009;20&#x02009;nm every minute. Experiments were repeated three times. The detail information of IC<sub>50</sub> calculation is in Supplementary Information.</p></sec><sec id="Sec16"><title>Immunofluorenscence assay</title><p id="Par22">One thousand SGC-7901 cells were cultured for 24&#x02009;h in 96-well plates, followed by treatment with <bold>7p</bold>, CA-4 or 0.05% DMSO for the indicated times. After treatment, the cells were fixed with 4% formaldehyde in PBS, washed twice with PBS and permeabilised with 0.1% (v/v) Triton X-100 in PBS for 5&#x02009;min. Then, cells were blocked with 5% bovine serum albumin (BSA) in PBS for 10&#x02009;min. Microtubules were detected using a monoclonal anti-a-tubulin antibody diluted 1:50 in PBS overnight at 4&#x02009;&#x000b0;C and a FITC conjugated secondary antibody diluted 1:200 in PBS for 1&#x02009;h at 37&#x02009;&#x000b0;C. After nuclear counter staining with DAPI (1&#x02009;mg/mL), the cells were imaged using a fluorescence microscope. Experiments were repeated three times.</p></sec><sec id="Sec17"><title>Cell cycle analysis</title><p id="Par23">One million SGC-7901 cells were incubated with <bold>7p</bold> (52&#x02009;nM), CA-4 (48&#x02009;nM) or 0.05% DMSO (control) for the indicated times. The cells were collected by centrifugation, washed with PBS and fixed in ice-cold 70% ethanol. The fixed cells were harvested by centrifugation and resuspended in 500&#x02009;mL of PBS containing 50&#x02009;mg/mL RNase. After 30&#x02009;min incubation at 37&#x02009;&#x000b0;C, cells were stained with 50&#x02009;mg/mL PI at 4&#x02009;&#x000b0;C in the dark for 30&#x02009;min. Then, the samples were analysed by FACS can flow cytometry (BectoneDickinson, Franklin Lakes, NJ, USA). Experiments were repeated at least three times.</p></sec><sec id="Sec18"><title>Competitive tubulin-binding assay</title><p id="Par24">
<bold>7p</bold>, CA-4 and Taxol were carried out at various concentrations containing 5&#x02009;&#x003bc;M of tubulin and colchicine for 60&#x02009;min at 37&#x02009;&#x000b0;C. Fluorescence values are normalized to DMSO (control), F/F<sub>0</sub> represents inhibition rate (IR&#x02009;=&#x02009;F/F<sub>0</sub>) whereas F<sub>0</sub> refers to fluorescence of the 5&#x02009;&#x003bc;M colchicine&#x02013;tubulin complex, and F describes the fluorescence of a given concentrations (1.5&#x02009;&#x003bc;M, 5&#x02009;&#x003bc;M and 15&#x02009;&#x003bc;M) of <bold>7p</bold>, CA-4 and Taxol competition with the 5&#x02009;&#x003bc;M colchicine&#x02013;tubulin complex.</p></sec><sec id="Sec19"><title>DFT computations</title><p id="Par25">The molecules was prepared by Avogadro (Version 1.20)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, and optimized by molecular dynamic forcefield MMFF94<sup><xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref></sup>. Then, all molecules were fully optimized by DFT basic set B3LYP/6-31&#x02009;G(d) on Gaussian 09<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Solvent effects were computed using the CPCM<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> model. After fully optimization, the energy of three tautomer was obtained for compare. The raw data with unit a.u. are transformed to kJ/mol (1 a.u.&#x02009;=&#x02009;2625.5&#x02009;kJ/mol). All date are provided on Supplementary Information.</p></sec><sec id="Sec20"><title>Molecular modeling studies</title><p id="Par26">Molecular docking was carried out by Discovery Studio 3.5 with LibDock program. The 3D structure of 3HKC in docking study was downloaded from Protein Data Bank. The docking poses were selected according to previously studies<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p></sec></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec21"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_17449_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-017-17449-0.</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We gratefully acknowledge the National Natural Science Foundation of China (81673293, 81502932, 81602969, 81641128), Program for Liaoning Excellent Talents in University (LR2013046) and State Key Laboratory of Natural Medicines and Active Substance (No. GTZK201603) for their generous financial support.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>Yue Wu, D. Feng, M. Gao, P. Yan, Z. Gu performed the experiments. Yue Wu, D. Feng, Z. Wang, Q. Guan, D. Zuo, K. Bao, J. Sun, Yingliang Wu, W. Zhang analyzed, interpreted the data and wrote the paper.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par27">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>MA</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name></person-group><article-title>Microtubules as a target for anticancer drugs</article-title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><fpage>253</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nrc1317</pub-id><pub-id pub-id-type="pmid">15057285</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>DD</given-names></name></person-group><article-title>An overview of tubulin inhibitors that interact with the colchicine binding site</article-title><source>Pharm Res</source><year>2012</year><volume>29</volume><fpage>2943</fpage><lpage>2971</lpage><pub-id pub-id-type="doi">10.1007/s11095-012-0828-z</pub-id><pub-id pub-id-type="pmid">22814904</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettit</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6</article-title><source>Journal of Medicinal Chemistry</source><year>1995</year><volume>38</volume><fpage>1666</fpage><lpage>1672</lpage><pub-id pub-id-type="doi">10.1021/jm00010a011</pub-id><pub-id pub-id-type="pmid">7752190</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risinger</surname><given-names>AL</given-names></name><etal/></person-group><article-title>ELR510444, a novel microtubule disruptor with multiple mechanisms of action</article-title><source>J Pharmacol Exp Ther</source><year>2011</year><volume>336</volume><fpage>652</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1124/jpet.110.175331</pub-id><pub-id pub-id-type="pmid">21148249</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>MC</given-names></name><name><surname>Luduena</surname><given-names>RF</given-names></name></person-group><article-title>The effect of TN-16 on the alkylation of tubulin</article-title><source>Biochemical and Biophysical Research Communications</source><year>1985</year><volume>129</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(85)91422-6</pub-id><pub-id pub-id-type="pmid">4004874</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasylyk</surname><given-names>C</given-names></name><etal/></person-group><article-title>Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><fpage>1275</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2674</pub-id><pub-id pub-id-type="pmid">18316589</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>A</given-names></name><name><surname>Giardina</surname><given-names>C</given-names></name></person-group><article-title>Novel Piperazine-based Compounds Inhibit Microtubule Dynamics and Sensitize Colon Cancer Cells to Tumor Necrosis Factor-induced Apoptosis</article-title><source>Journal of Biological Chemistry</source><year>2014</year><volume>289</volume><fpage>2978</fpage><lpage>2991</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.499319</pub-id><pub-id pub-id-type="pmid">24338023</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dheer</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Shankar</surname><given-names>R</given-names></name></person-group><article-title>Medicinal attributes of 1,2,3-triazoles: Current developments</article-title><source>Bioorg Chem</source><year>2017</year><volume>71</volume><fpage>30</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2017.01.010</pub-id><pub-id pub-id-type="pmid">28126288</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>D</given-names></name><etal/></person-group><article-title>Synthesis and antiproliferative activity of 2-aryl-4-(3,4,5-trimethoxybenzoyl)-1,2,3-triazol derivatives as microtubule-destabilizing agents</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>29103</fpage><lpage>29111</lpage><pub-id pub-id-type="doi">10.1039/C7RA02720F</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madadi</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4</article-title><source>Eur J Med Chem</source><year>2015</year><volume>103</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2015.08.041</pub-id><pub-id pub-id-type="pmid">26352674</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy</article-title><source>J Med Chem</source><year>2013</year><volume>56</volume><fpage>9008</fpage><lpage>9018</lpage><pub-id pub-id-type="doi">10.1021/jm400840p</pub-id><pub-id pub-id-type="pmid">24160376</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Journet</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>D</given-names></name><name><surname>Kowal</surname><given-names>JJ</given-names></name><name><surname>Larsen</surname><given-names>RD</given-names></name></person-group><article-title>Highly efficient and mild synthesis of variously 5-substituted-4-carbaldehyde-1,2,3-triazole derivatives</article-title><source>Tetrahedron Letters</source><year>2001</year><volume>42</volume><fpage>9117</fpage><lpage>9118</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)01923-2</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>ZQ</given-names></name><name><surname>Wang</surname><given-names>CI</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Yin</surname><given-names>BZ</given-names></name></person-group><article-title>Efficient and Rapid Method for the Oxidation of Electron&#x02010;Rich Aromatic Aldehydes to Carboxylic Acids Using Improved Basic Hydrogen Peroxide</article-title><source>Synthetic Communications</source><year>2006</year><volume>36</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1080/00397910500408456</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trofimov</surname><given-names>B</given-names></name><etal/></person-group><article-title>Click Chemistry with 2-Ethynyl-4,5,6,7-tetrahydroindoles: Towards Functionalized Tetrahydroindole-Triazole Ensembles</article-title><source>Synthesis</source><year>2013</year><volume>45</volume><fpage>678</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1318149</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Chen, Y., Liu, Y., Petersen, J. L. &#x00026; Shi, X. Conformational control in the regioselective synthesis of N-2-substituted-1,2,3-triazoles. <italic>Chem Commun (Camb</italic>), 3254&#x02013;3256, 10.1039/b805328f (2008).</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Metal- and Base-Free Three-Component Reaction of Ynones, Sodium Azide, and Alkyl Halides: Highly Regioselective Synthesis of 2,4,5-Trisubstituted 1,2,3-NH-Triazoles</article-title><source>Synlett</source><year>2010</year><volume>2010</volume><fpage>1617</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1258086</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Krishnamurthy</surname><given-names>D</given-names></name><name><surname>Senanayake</surname><given-names>CH</given-names></name><name><surname>Wipf</surname><given-names>P</given-names></name></person-group><article-title>General solution to the synthesis of N-2-substituted 1,2,3-triazoles</article-title><source>Org Lett</source><year>2010</year><volume>12</volume><fpage>4632</fpage><lpage>4635</lpage><pub-id pub-id-type="doi">10.1021/ol101965a</pub-id><pub-id pub-id-type="pmid">20863126</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasovskiy</surname><given-names>A</given-names></name><name><surname>Straub</surname><given-names>BF</given-names></name><name><surname>Knochel</surname><given-names>P</given-names></name></person-group><article-title>Highly efficient reagents for Br/Mg exchange</article-title><source>Angew Chem Int Ed Engl</source><year>2005</year><volume>45</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1002/anie.200502220</pub-id><pub-id pub-id-type="pmid">16307460</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaura</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name></person-group><article-title>A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides</article-title><source>Tetrahedron Letters</source><year>1979</year><volume>20</volume><fpage>3437</fpage><lpage>3440</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)95429-2</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>ZL</given-names></name><etal/></person-group><article-title>A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells <italic>in vitro</italic> through disruption of microtubule</article-title><source>Acta Pharmacol Sin</source><year>2012</year><volume>33</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1038/aps.2011.156</pub-id><pub-id pub-id-type="pmid">22301862</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanwell</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</article-title><source>J Cheminform</source><year>2012</year><volume>4</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-4-17</pub-id><pub-id pub-id-type="pmid">22889332</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>TA</given-names></name></person-group><article-title>Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</article-title><source>Journal of Computational Chemistry</source><year>1996</year><volume>17</volume><fpage>490</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;490::AID-JCC1&#x0003e;3.0.CO;2-P</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>TA</given-names></name></person-group><article-title>Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions</article-title><source>Journal of Computational Chemistry</source><year>1996</year><volume>17</volume><fpage>520</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;520::AID-JCC2&#x0003e;3.0.CO;2-W</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>TA</given-names></name></person-group><article-title>Merck molecular force field. III</article-title><source>Molecular geometries and vibrational frequencies for MMFF94. Journal of Computational Chemistry</source><year>1996</year><volume>17</volume><fpage>553</fpage><lpage>586</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>TA</given-names></name><name><surname>Nachbar</surname><given-names>RB</given-names></name></person-group><article-title>Merck molecular force field. IV. conformational energies and geometries for MMFF94</article-title><source>Journal of Computational Chemistry</source><year>1996</year><volume>17</volume><fpage>587</fpage><lpage>615</lpage></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halgren</surname><given-names>TA</given-names></name></person-group><article-title>Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules</article-title><source>Journal of Computational Chemistry</source><year>1996</year><volume>17</volume><fpage>616</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&#x0003c;616::AID-JCC5&#x0003e;3.0.CO;2-X</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Gaussian 09 (Gaussian, Inc., Wallingford CT, 2009).</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname><given-names>V</given-names></name><name><surname>Cossi</surname><given-names>M</given-names></name></person-group><article-title>Quantum Calculation of Molecular Energies and Energy Gradients in Solution by a Conductor Solvent Model</article-title><source>The Journal of Physical Chemistry A</source><year>1998</year><volume>102</volume><fpage>1995</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1021/jp9716997</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossi</surname><given-names>M</given-names></name><name><surname>Rega</surname><given-names>N</given-names></name><name><surname>Scalmani</surname><given-names>G</given-names></name><name><surname>Barone</surname><given-names>V</given-names></name></person-group><article-title>Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model</article-title><source>J Comput Chem</source><year>2003</year><volume>24</volume><fpage>669</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1002/jcc.10189</pub-id><pub-id pub-id-type="pmid">12666158</pub-id></element-citation></ref></ref-list></back></article>